Abstract
As the epidemic of obesity continues to infest the world population at alarming proportions, researchers have started to focus on the endocrine aspect of its basic unit: the adipocyte. The last two decades have proved beneficial in understanding the impact of adipocytes, specifically the metabolic influences of its hormones, the adipocytokines. This review focuses on our current understanding of leptin and adiponectin, two of the most studied and established adipocytokines. Patents regarding leptin and adiponectin are highlighted.
Keywords: Leptin, adiponectin, patents
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery
Title: Advancement in Obesity Management: Leptin and Adiponectin Patents
Volume: 2 Issue: 3
Author(s): Nasser M. Al-Daghri
Affiliation:
Keywords: Leptin, adiponectin, patents
Abstract: As the epidemic of obesity continues to infest the world population at alarming proportions, researchers have started to focus on the endocrine aspect of its basic unit: the adipocyte. The last two decades have proved beneficial in understanding the impact of adipocytes, specifically the metabolic influences of its hormones, the adipocytokines. This review focuses on our current understanding of leptin and adiponectin, two of the most studied and established adipocytokines. Patents regarding leptin and adiponectin are highlighted.
Export Options
About this article
Cite this article as:
Al-Daghri M. Nasser, Advancement in Obesity Management: Leptin and Adiponectin Patents, Recent Patents on Endocrine, Metabolic & Immune Drug Discovery 2008; 2 (3) . https://dx.doi.org/10.2174/187221408786241793
DOI https://dx.doi.org/10.2174/187221408786241793 |
Print ISSN 1872-2148 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3334 |
Related Articles
-
Pharmacological Approaches for Treatment-resistant Bipolar Disorder
Current Neuropharmacology Effects of Galantamine in Alzheimers Disease: Double-blind Withdrawal Studies Evaluating Sustained Versus Interrupted Treatment
Current Alzheimer Research Neuroprotective Strategies for Parkinsons Disease
Current Neuropharmacology Editorial [ Proteases and Phospholipases in CNS Disorders Guest Editor: Swapan K. Ray ]
CNS & Neurological Disorders - Drug Targets Antioxidant Status and Energy State of Erythrocytes in Alzheimer Dementia: Probing for Markers
CNS & Neurological Disorders - Drug Targets The Role of Inflammatory Biomarkers in the Detection and Therapy of Atherosclerotic Disease
Current Vascular Pharmacology Neuroinflammation: Microglial Activation During Sepsis
Current Neurovascular Research Dopamine Neurotransmission and Atypical Antipsychotics in Prefrontal Cortex: A Critical Review
Current Topics in Medicinal Chemistry Drug Targeting to the Brain - A Review
Current Nanoscience The Blood Brain Barrier and its Role in Alzheimer's Therapy: An Overview
Current Drug Targets Functional and Structural MRI Biomarkers to Detect Pre-Clinical Neurodegeneration
Current Alzheimer Research A Series of Novel Neuroprotective Blood Brain Barrier Penetrating Flavonoid Drugs to Treat Acute Ischemic Stroke
Current Pharmaceutical Design Bayes Syndrome and Imaging Techniques
Current Cardiology Reviews Preventing the Spread of Alzheimer’s Disease Neuropathology: A Role for Calcilytics?
Current Pharmaceutical Biotechnology Prevention of Ischemic Stroke: Antithrombotic Therapy in Cardiac Embolism
Current Drug Targets Erythrocyte Associated Amyloid-β as Potential Biomarker to Diagnose Dementia
Current Alzheimer Research Current Issues in the Use of fMRI-Based Neurofeedback to Relieve Psychiatric Symptoms
Current Pharmaceutical Design Biotechnological Engineering of Heparin/Heparan Sulphate: A Novel Area of Multi-Target Drug Discovery
Current Pharmaceutical Design Therapeutic Potential of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors for the Treatment of Retinal and Eye Diseases
CNS & Neurological Disorders - Drug Targets Neuroprotective Effects of Quercetin: From Chemistry to Medicine
CNS & Neurological Disorders - Drug Targets